Compliance Rate
Compliance Rate
0.0%
Compliant submissions
0
Incompliant submissions
1
Total trials
1
My Organizations' Clinical Trials
Showing 1575 of 1949 entries
View as:
Phase: N/A
Priority: Normal
Start: 06/30/12
End: 05/31/14
Due: 05/31/15
Phase: N/A
Priority: Normal
Start: 01/10/19
End: 11/21/23
Due: 11/21/24
Phase: N/A
Priority: Normal
Start: 05/31/05
End: 10/31/10
Due: 10/31/11
Phase: N/A
Priority: Normal
Start: 11/13/15
End: 04/19/17
Due: 04/19/18
Phase: N/A
Priority: Normal
Start: 04/03/20
End: 04/30/21
Due: 04/30/22
Phase: N/A
Priority: Normal
Start: 03/09/21
End: 06/11/21
Due: 06/11/22
Phase: N/A
Priority: Normal
Start: 05/31/06
End: 12/31/13
Due: 12/31/14
Phase: N/A
Priority: Normal
Start: 10/15/21
End: 02/15/26
Due: 02/15/27
Phase: N/A
Priority: Normal
Start: 03/31/12
End: 12/31/12
Due: 12/31/13
Phase: N/A
Priority: Normal
Start: 07/31/12
End: 12/31/14
Due: 12/31/15
Phase: N/A
Priority: Normal
Start: 03/31/11
End: 02/28/15
Due: 02/28/16
Phase: N/A
Priority: Normal
Start: 10/30/19
End: 04/18/20
Due: 04/18/21
Phase: N/A
Priority: Normal
Start: 08/31/10
End: 06/30/13
Due: 06/30/14
Phase: N/A
Priority: Normal
Start: 05/31/12
End: 07/31/13
Due: 07/31/14
Phase: N/A
Priority: Normal
Start: 08/23/22
End: 03/03/23
Due: 03/03/24
Phase: N/A
Priority: Normal
Start: 01/07/19
End: 08/31/19
Due: 08/31/20
Phase: N/A
Priority: Normal
Start: 09/15/17
End: 03/25/19
Due: 03/25/20
Phase: N/A
Priority: Normal
Start: 11/28/22
End: 06/30/25
Due: 06/30/26
Phase: N/A
Priority: Normal
Start: 08/15/23
End: 05/31/25
Due: 05/31/26
Phase: N/A
Priority: Normal
Start: 08/01/25
End: 09/30/27
Due: 09/30/28
Feasibility of a Stigma Reduction Intervention for Human Immunodeficiency Virus (HIV)-Infected Women
Phase: N/A
Priority: Normal
Start: 07/31/11
End: 01/31/14
Due: 01/31/15
Phase: N/A
Priority: Normal
Start: 09/11/20
End: 11/21/22
Due: 11/21/23
Phase: N/A
Priority: Normal
Start: 03/31/11
End: 07/31/13
Due: 07/31/14
Phase: N/A
Priority: Normal
Start: 09/21/21
End: 06/08/23
Due: 06/08/24
Phase: N/A
Priority: Normal
Start: 09/30/14
End: 03/31/16
Due: 03/31/17